| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, HSE, ISO 9001, USP, BP |
| Suitable for: | Elderly, Children, Adult |
| State: | Solid |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
Pharmaceutical Intermediate Purity Lenalidomide Powder CAS 191732-72-6 Lenalidomide
| Product Name | Pharmaceutical Intermediate Purity Lenalidomide Powder CAS 191732-72-6 Lenalidomide |
| CAS | 191732-72-6 |
| Appearance | Milk White |
| Molecular formula | C13H13N3O3 |
| Molecular Weight | 259.26 |
| Assay | 98% |
| Shelf Life | 24 months when properly stored |
| Storage | Keep in a cool, dry, dark location |
|
What is Lenalidomide ?
Lenalidomide is indicated for the treatment of multiple myeloma in combination with . It is also indicated for the treatment of patients with transfusion-dependent anemia due to low- or intermediate- risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
|
Lenalidomide affects the immune system. It promotes immune responses to help slow tumor growth.
Lenalidomide treats anemia (a lack of red blood cells in the body), multiple myeloma (cancer resulting from a progressive
blood disease), and mantle cell lymphoma (a rare cancer of the lymph nodes). It is used in patients with myelodysplastic
syndrome caused by an abnormal chromosome. This disorder is also called deletion 5q MDS, because part of chromosome
5 is missing. In people with this disorder, the bone marrow does not produce enough healthy blood cells.
The product is used to treat morning sickness has caused thousands of birth defects Thalidomide (thalidomide) enhanced
version, with anti-cancer potential. Compared with thalidomide, fewer adverse reactions, studies have shown that it does
not cause birth defects.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}